Last reviewed · How we verify
Glanzmann's thrombasthenia
Approved treatments
- Eptacog Alfa · Novo Nordisk
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Glanzmann's thrombasthenia patent landscape — cliff calendar, originator estates, attackable patents
- Glanzmann's thrombasthenia treatment landscape brief
- Glanzmann's thrombasthenia treatment updates RSS
Frequently asked questions about Glanzmann's thrombasthenia
What drugs treat Glanzmann's thrombasthenia?
Tracked treatments include Eptacog Alfa.
What is the treatment for Glanzmann's thrombasthenia?
Standard treatment for Glanzmann's thrombasthenia includes Eptacog Alfa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Glanzmann's thrombasthenia patent cliff · Glanzmann's thrombasthenia CI report
- Treatment: Eptacog Alfa · Novo Nordisk
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing